660 likes | 1.4k Views
SOFT TISSUE TUMORS Early diagnosis. Nicolas SANS Hôpital Universitaire Purpan - Toulouse - FRANCE. This is not a muscular tear…. RHADOMYOSARCOMA. This is not a popliteal cyst…. LYMPHOMA. This is not an intramuscular hematoma …. ANGIOSARCOMA.
E N D
SOFT TISSUE TUMORS Early diagnosis Nicolas SANS Hôpital Universitaire Purpan - Toulouse - FRANCE
This is not a muscular tear… RHADOMYOSARCOMA
This is not a popliteal cyst… LYMPHOMA
ANGIOSARCOMA ANY MUSCULAR LESION WHICH DOES NOT EVOLVE BETWEEN 2 CONTROLS HAS TO MAKE EVOKE A TUMOR
EPIDEMIOLOGY BENIGN TUMORS 300 /100 000 MALIGNANT TUMORS 3 /100 000 Kransdorf et Murphey, 1997 • Soft Tissue Sarcomas • 2000 new cases per year in France
NATURAL HISTORY Centrifugal Longitudinal Fibro-vascular reaction
NATURAL HISTORY Centrifugal Longitudinal Fibro-vascular reaction Capsule (B) Pseudo capsule (M)
PHYSICAL SIGNS • deep mass, often little painful • duration of the symptoms ? • recent increase of volume ? • diameter > 5 cm
PROGNOSTIC FACTORS • Age > 50 ans • Male (±) • Location : head, neck, chest • Histological grade • Histological type (±) • SURGICAL MARGINS
The PROGNOSTIC depends on the initial surgical treatment R0 all tumour tissue was macroscopically removed with microscopically clear margins recurrence 10% for 5 years R1 microscopic residual disease or with close margins (less than 1 mm) recurrence 50% for 5 years R2 macroscopic residual disease recurrence 90% for 5 years Post operative irradiation can’t improve an incorrect surgery
COMPARTMENTAL ANATOMY Muscular fascia Enthesis Cartilage Cortical bone Periost UNI PLURI Anderson MW et al. AJR 1999
GOALS • To define the most sensitive technique in the detection of the masses of soft tissues • To estimate the most specific technique as for the differentiation between a benign and malignant tumor • To appreciate the operability and participate in the therapeutic planification • To approach the histological nature
INITIAL DIAGNOSIS In few cases images are pathognomonic
Fibrolipoma of the median nerve Courtesy D Godefroy
PLAIN RADIOGRAPHS • Frequently unrewarding
PLAIN RADIOGRAPHS • Sometimes evokes the diagnosis
SONOGRAPHY • cystic vs solid lesions • calficiations • to eliminate an hematoma
MRI Morphological Analysis - Signal analysis • Multiplanar study (axial +++) • T1 weighted - T2 weighted • Pre and post Gadolinium injection • With and without fat saturation • Dynamic study • MRA
Depth & Size Superficial : « benign » If size < 3 cm Deep : « malignant » If size > 5 cm
well defined margins Sarcoma
Poor defined margins T Hematoma
Poor defined margins Desmoid tumor
Crossing a Fascia Extra compartmental
Crossing a Fascia Fibromatosis Vascular tumor Nervous tumor
NOT WITHOUT FAT SAT !!! Synovialosarcoma Gielen, JCAT 2003
NOT WITHOUT FAT !!! T1 Fat Sat Gado
NOT WITHOUT FAT !!! T1 Fat Sat Gado
Heterogeneous or hyperintense on T1 Synovialosarcoma Liposarcoma Se +++ Sp ---
Homogeneous signal on T1 Heterogeneous on T2 T1 T2 Se = 72-80% Sp = 87-91% Leiomyosarcoma
Low signal intensity of the septa on T2 Liposarcoma
Fast and prolonged enhancement T2 T1 Fat Sat Gado
MRI • Lesion of more than 50 mm in diameter • Deep localization • Irregular or lobulated margins • Irregular or tick septa • Heterogeneous signal on T1 and T2 • Low signal intensity of the septa on T2 • Fast and prolonged enhancement • Necrosis more than > 50% MORPHOLOGY SIGNAL KRANSDORF, 2000; DESCHEPPER, 2000; VARMA, 1999;CEUGNART,2002
PATHOLOGY GOALS • To differentiate begnin or malignant tumor • To confirm that it is indeed a conjunctival tumor (vs lymphoma, metastasis…) • Define the type of surgery which must be realized (enucleation for conjunctival tumor, extended resection for sarcoma) • To discuss a neoadjuvant treatment
PATHOLOGY • Microbiopsy • Biopsy excision • Surgical biopsy
PATHOLOGY Tissue sample • Formol fixation • Freezing - Cryosection molecular study X
PATHOLOGY Tissue sample • Formol fixation • Freezing - Cryosection molecular study X Pathologist !
PATHOLOGY Tissue sample • Formol fixation • Freezing - Cryosection molecular study X Pathologist !
BIOPSY What you should not make • Perform the biopsy before the MRI • Compromise or complicate the later treatment by an unsuitable way
BIOPSY What you should not make • Perform the biopsy before the MRI • Compromise or complicate the later treatment by an unsuitable way • Obtain insufficient samples
CONCLUSION (1) • The initial medical management of a soft tissue sarcoma is essential for the future of patient • Think of a sarcoma when : • Size more than 5 cm • Deep • Symptomatic lesion
CONCLUSION (2) MULTIDISCIPLINARY CONCERTATION • MRI • Discuss the therapeutic plan before any surgical procedure • Biopsy • Experimented pathologist • Freezing • PHRC